Similarly, circulating A2M (Fig. 5H, 1.38 fold, p < 0.05) and TNFRSF11B (Fig. 5I, 1.47 fold, p < 0.001) were significantly higher in NAFLD patients than HCs. Here, TNFRSF11B is linked to metabolic dysfunction-associated steatotic liver disease.